Literature DB >> 8471537

Progressive splenomegaly with increasing extramedullary haematopoiesis in subcutaneous 9L-glioma bearing rats.

H Imaya1, M Kudo, H Matsuura.   

Abstract

We have succeeded in inducing progressive splenomegaly by inoculating 9L-glioma cells into the back subcutaneous regions of Fischer rats. The progressive splenomegaly was histologically characterized by progressively increased extramedullary haematopoiesis. Immunohistochemically Leu 7 positive cells were present in the enlarged spleen, suggesting that the spleen possessed natural killer (NK) cells. However, the splenic NK cell activity obtained in a 4h-51Cr release assay at 5 weeks after inoculation was below 5%, suggesting that the cytotoxic function of the NK cells was depressed. Bone marrow morphologically appeared not to be suppressed. Although the exact cause and mechanism of the progressive splenomegaly with prominent extramedullary haematopoiesis and severe suppression of the splenic NK cell activity remains speculative at present, it could be a unique manifestation of a systemic host-reaction reflected by the 9L-glioma continuously growing in the subcutaneous regions. This experiment could be a useful approach to the study of splenic and other reticuloendothelial roles in host-immunity in the tumour bearing state.

Entities:  

Mesh:

Year:  1993        PMID: 8471537      PMCID: PMC2002216     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  11 in total

1.  Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.

Authors:  S Fujimoto; M I Greene; A H Sehon
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

2.  Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.

Authors:  S Fujimoto; M I Greene; A H Sehon
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

3.  Suppression of splenic natural killer cell activity in rats with brain tumors.

Authors:  H Imaya; H Matsuura; M Kudo; S Nakazawa
Journal:  Neurosurgery       Date:  1988-07       Impact factor: 4.654

4.  Natural killer cells: definition of a cell type rather than a function.

Authors:  L L Lanier; J H Phillips; J Hackett; M Tutt; V Kumar
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

5.  Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture.

Authors:  P Benda; K Someda; J Messer; W H Sweet
Journal:  J Neurosurg       Date:  1971-03       Impact factor: 5.115

6.  Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.

Authors:  K D Elgert; W L Farrar
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

7.  A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).

Authors:  T Abo; C M Balch
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

8.  Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon.

Authors:  E H Steinhauer; A T Doyle; J Reed; A S Kadish
Journal:  J Natl Cancer Inst       Date:  1985-12       Impact factor: 13.506

9.  Immunohistochemical assessment of splenic lymphocyte and macrophage subpopulations in patients with gastric cancer.

Authors:  S Falk; G Seipelt; H Müller; H J Stutte
Journal:  Cancer       Date:  1989-10-15       Impact factor: 6.860

10.  T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta.

Authors:  M Wrann; S Bodmer; R de Martin; C Siepl; R Hofer-Warbinek; K Frei; E Hofer; A Fontana
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.